Dexcom's landmark CONNECT trial, now published in the NEJM, could drive a pivotal CMS coverage decision for type 2 diabetes patients this year.

Resmed CMO Carlos Nunez discusses the Oura and Eight Sleep partnerships, consumer data opt-in trends, and the company's long-term sleep health strategy.

Make no mistake about it, history was made in Florida on Oct. 25, and the surgical team’s excitement is well earned. Next comes the hard part — getting regulatory, reimbursement, and hospital ...

Expanding medical devices into global markets requires manufacturers to navigate diverse regulatory frameworks, testing requirements, quality management expectations, and country-specific approval ...

Dyconex created a biocompatible PCB platform that shrinks medical device interconnects while boosting functionality and ...

Stryker lowered its 2026 sales and EPS guidance after a Q3 miss, citing slowing joint replacement demand and ...

Inside Braile Biomédica's factory floor: hand-sewn heart valves, bovine tissue, and the single fiber supplier behind every oxygenator worldwide.

As senior content director for the Informa Markets—Engineering portfolio of business-to-business media, Jamie Hartford works with the editorial teams at Medical Device + Diagnostic Industry (MD+DI), ...

Mark McCarty has arguably the deepest reservoir of experience in med tech regulatory matters in all of the trade press. His experience includes managing editorship of publications such as Warning ...

Distalmotion CEO Greg Roche discusses DEXTER's ASC-first design, the company's $70M Perceptive Advisors financing, and ...